ArticleBMC pregnancy and childbirth2025
Prevalence and risk factors of postpartum depression, anxiety, and comorbidity of both disorders: a cross-sectional study.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- "Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPostpartum depression (PPD) and postpartum anxiety (PPA) are common perinatal mental disorders affecting maternal and infant health. However, the epidemiological characteristics and risk factors of PPD, PPA, and the comorbidity of both disorders remain inadequately investigated.
methodsThe cohort of this cross-sectional study included 2,152 postpartum women. The Patient Health Questionnaire-9 (PHQ-9), Edinburgh Postnatal Depression Scale (EPDS), and Generalized Anxiety Disorder-7 were used to assess symptoms of PPD and PPA.
resultsThe self-reported point prevalence rates of PPD, PPA, and their comorbidity were 12.9%, 20.8%, and 9.4%, respectively. Among the participants, 12.9% and 8.4% experienced moderate-to-severe symptoms of PPD and PPA, respectively. Spearman’s correlation analysis revealed a correlation between the total PHQ-9 and EPDS scores (r = 0.404, p < 0.001). Sleep duration < 6 h was associated with increased risks of symptoms of PPD (RR = 1.862, p < 0.001), while sleep duration > 8 h was a protective factor for PPA symptoms (RR = 0.795, p = 0.024). A low annual household income was significantly correlated with higher risks for symptoms of PPD (RR = 3.369, p < 0.001) and PPA (RR = 2.148, p < 0.001).
conclusionThis study revealed high prevalence rates of PPD and PPA, with frequent comorbidity. These findings suggest the importance of combined screening of women for both PPD and PPA, with particular attention to sleep quality and economic status.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.